MAR 06, 2018 08:00 AM PST

Performance assessment of RNA sequencing and expression arrays for transcriptome analysis in cancer research

Speakers
  • Research Scientist, Bioinformatics and Modelling Group, Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health
    Biography
      Dr. Petr Nazarov is a Research Scientist in the Proteome and Genome Research Unit of the Department of Oncology at Luxembourg Institute of Health and an invited Assistant Professor at Luxembourg University. Dr. Nazarov produced over 30 publications devoted to data analysis and oncology. His primary expertise is biostatistics, machine learning and genomics. His recent work focuses on characterizing transcriptional variations in peritumoral tissue environment of pancreatic cancer, as well as tumors originated from lung, colon, skin and brain. His current research leverages deconvolution of transcriptomic signals from heterogeneous tumors to improve cancer classification.

    Abstract:

    DATE: March 6, 2018
    TIME: 08:00am PST, 11:00am EST, 5:00pm CET

    RNA sequencing and expression arrays are transcriptomics techniques used to quantify transcribed genes and their isoforms. The first part of the talk will compare RNA-seq and array performance for the analysis of differences between normal lung epithelium tissue and squamous cell carcinoma lung tumors. High concordance for protein-coding gene expression was observed between the platforms. However, much more discrepant results were obtained for the detection of less abundant transcripts, including long non-coding RNAs and alternatively spliced variants. The second part of the talk will describe the method that can help combine results from different platforms and analyze data generated from bulk heterogeneous samples, called independent component analysis.

    In this webinar, the speaker will:

    • Describe the results of platform comparison for protein-coding and long non-coding genes
    • Explain the biases observed in RNA-seq and expression array platforms
    • Share insights on how deconvolution of transcriptomics data followed by machine learning can improve tumor classification

     

    For Research Use Only. Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    AUG 15, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 15, 2019 09:00 AM PDT
    DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
    Loading Comments...
    Show Resources